High cut-off Continuous venovenous haemodialysis (CVVHD) to improve haemodynamic stability and Organ function scores in patients treated for acute renal failure after Systemic inflammatory response Syndrome (SIRS)/septic shock
- Conditions
- Acute renal failure after SIRS/septic shockUrological and Genital DiseasesRenal failure
- Registration Number
- ISRCTN77656437
- Lead Sponsor
- Gambro Dialysatoren GmbH (Germany)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 120
1. Fulfilling at least two of the SIRS criteria as defined by the American College of Chest Physicians (ACCP)/Society of Critical Care Medicine (SCCM) Consensus Conference
2. Having signs of renal dysfunction
3. Requirement for catecholamine administration (norepinephrine or others)
4. Acute Physiology And Chronic Health Evaluation (APACHE II) score at enrolment greater than or equal to 19 and less than or equal to 30
1. Lack of written informed consent from patients or a legally authorized surrogate
2. Duration of septic shock greater than 4 days
3. Hypoproteinaemia (characterized by serum albumin less than 18 g/l)
4. End stage renal failure
5. Known active malignancy
6. Known human immunodeficiency virus (HIV), hepatitis B virus (HBV) or hepatitis C virus (HCV) infection
7. Age younger than 18 years or older than 80 years
8. Known pregnancy
9. Immunosuppression after transplantation
10. Participation in another clinical study
11. Renal replacement therapy greater than 24 hours before randomisation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <br> 1. Dosage of vasopressors<br> 2. Mean arterial pressure<br> 3. Heart rate<br> 4. Central venous pressure<br>
- Secondary Outcome Measures
Name Time Method <br> 1. Sequential Organ Failure Assessment (SOFA) score<br> 2. Survival at 28 days<br> 3. Length of need for catecholamine application<br> 4. Length of need for mechanical ventilation<br> 5. Length of need for renal replacement therapy<br> 6. Length of stay in intensive care unit (ICU)<br>